Furthermore, Zhou et al. reported that circ-Foxo3 and Foxo3 expressed low in AML patients compared to control group and patients with high expression of Foxo3 often revealed a trend of better prognosis (Zhou et al., 2019) (Figure 5A). The gene discussed is FOXO3; the disease is acute myeloid leukemia.